Effusive FIP Molnupiravir Tablets Non Effusive FIP CAS 2349386-89-4

Molnupiravir tablets are a specialized antiviral medication designed to treat feline infectious peritonitis (FIP) in cats. FIP is a severe and often fatal disease caused by a mutation of the feline coronavirus.

The active ingredient, Molnupiravir, works by disrupting viral RNA replication. When incorporated into the viral RNA, it induces mutations that prevent effective virus replication, thereby controlling the infection.

This treatment offers a promising solution for a previously difficult-to-manage condition. When administered at proper veterinary-prescribed dosages (based on weight, age, and health status), it can help alleviate FIP symptoms including fever, appetite loss, lethargy, and abdominal swelling.

Molnupiravir Tablets provide targeted treatment for feline infectious peritonitis (FIP) by interfering with viral replication at the molecular level.

After ingestion, Molnupiravir metabolizes into its active form and integrates into viral RNA during replication. This causes extensive mutations that prevent proper viral protein synthesis, significantly reducing viable virus production.

By inhibiting viral replication, these tablets help:

• Slow FIP progression
• Alleviate symptoms (lethargy, appetite loss, weight loss)
• Reduce fluid accumulation in body cavities
• Support immune system response